Unmasking the information encoded as structural motifs of viral RNA genomes: A potential antiviral target

Reviews in Medical Virology

Volumn 23, Issue 6, 2013, Pages 340-354

  Romero López, Cristina ^a   Berzal Herranz, Alfredo ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; APTAMER; BENZIMIDAZOLE DERIVATIVE; GENOMIC RNA; INITIATION FACTOR 2; INITIATION FACTOR 3; INITIATION FACTOR 4A; INITIATION FACTOR 4B; INITIATION FACTOR 4G; MACROGOL; PAROMOMYCIN; PEPTIDE VACCINE; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; SPACER DNA; SYNTHETIC PEPTIDE; TRANSFER RNA; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIVIRAL THERAPY; APHTHOVIRUS; COMBINATORIAL CHEMISTRY; CONFORMATIONAL TRANSITION; CORONAVIRUS; COXSACKIE VIRUS; DICISTROVIRIDAE; ENTEROVIRUS; FLAVIVIRUS; FOOT AND MOUTH DISEASE VIRUS; GENOMIC INSTABILITY; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERACTIONS WITH RNA; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PEPTIDE LIBRARY; POLIOMYELITIS VIRUS; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS; RIBOSOME SUBUNIT; RNA BINDING; RNA DEGRADATION; RNA FOLDING; RNA REPLICATION; RNA SYNTHESIS; RNA VIRUS; START CODON; STOP CODON; TRANSLATION INITIATION; VIRUS GENOME; VIRUS REPLICATION; VIRUS VIABILITY;

ANTIVIRAL AGENTS; HUMANS; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; RNA VIRUSES; RNA, VIRAL; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84887155360     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1756     Document Type: Review

References (153)

1. Schuster P. RNA based evolutionary optimization. Orig Life Evol Biosph 1993; 23: 373-391.
2. Eigen M. Error catastrophe and antiviral strategy. Proceedings of the National academy of Sciences of the USA 2002; 99: 13374-13376. DOI: 10.1073/pnas.212514799
3. Wagner A, Stadler PF. Viral RNA and evolved mutational robustness. Journal of Exposure Zoological 1999; 285: 119-127. DOI: 10.1002/(SICI)1097-010X(19990815)285:2<119::AID-JEZ4>3.0.CO;2-D
4. Contreras AM, Hiasa Y, He W, et al. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. Journal of Virology 2002; 76: 8505-8517.
5. Churkin A, Cohen M, Shemer-Avni Y, et al. Bioinformatic analysis of the neutrality of RNA secondary structure elements across genotypes reveals evidence for direct evolution of genetic robustness in HCV. Journal of Bioinformatics and Computational Biology 2010; 8: 1013-1026. DOI: S0219720010005087
6. Wan Y, Kertesz M, Spitale RC, et al. Understanding the transcriptome through RNA structure. Nature Reviews Genetics 2011; 12: 641-655. DOI: 10.1038/nrg3049
7. Liu Y, Wimmer E, Paul AV. cis-Acting RNA elements in human and animal plus-strand RNA viruses. Biochemical et Biophysical Acta 2009; 1789: 495-517. DOI: 10.1016/j.bbagrm.2009.09.007
8. Appel N, Schaller T, Penin F, et al. From structure to function: new insights into hepatitis C virus RNA replication. Journal Biological Chemistry 2006; 281: 9833-9836. DOI: R500026200
9. Fernández-Miragall O, López de Quinto S, Martínez-Salas E. Relevance of RNA structure for the activity of picornavirus IRES elements. Virus Research 2009; 139: 172-182. DOI: 10.1016/j.virusres.2008.07.009
10. Roberts L, Holcik M. RNA structure: new messages in translation, replication and disease. Workshop on the role of RNA structures in the translation of viral and cellular RNAs. EMBO Reports 2009; 10: 449-453. DOI: 10.1038/embor.2009.56
11. Reineke LC, Lloyd RE. Animal virus schemes for translation dominance. Current Opinion in Virology 2011; 1: 363-372. DOI: 10.1016/j.coviro.2011.10.009.
12. Schlesinger S, Makino S, Linial ML. cis-Acting genomic elements and trans-acting proteins involved in the assembly of RNA viruses. Seminars in Virology 1994; 5: 39-49.
13. Thurner C, Witwer C, Hofacker IL, et al. Conserved RNA secondary structures in Flaviviridae genomes. Journal of General Virology 2004; 85: 1113-1124.
14. Nakashima N, Uchiumi T. Functional analysis of structural motifs in dicistroviruses. Virus Research 2009; 139: 137-147. DOI: 10.1016/j.virusres.2008.06.006
15. Zoll J, Heus HA, van Kuppeveld FJ, et al. The structure-function relationship of the enterovirus 3'-UTR. Virus Research 2009; 139: 209-216. DOI: 10.1016/j.virusres.2008.07.014
16. Filbin ME, Kieft JS. Toward a structural understanding of IRES RNA function. Current Opinion in Structural Biology 2009; 19: 267-276. DOI: 10.1016/j.sbi.2009.03.005
17. Jan E, Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. Journal of Molecular Biology 2002; 324: 889-902. DOI: 10.1016/s0022-2836(02)01099-9
18. Wilson JE, Pestova TV, Hellen CU, et al. Initiation of protein synthesis from the A site of the ribosome. Cell 2000; 102: 511-520. DOI: 10.1016/S0092-8674(00)00055-6
19. Kanamori Y, Nakashima N. A tertiary structure model of the internal ribosome entry site (IRES) for methionine-independent initiation of translation. RNA 2001; 7: 266-274.
20. Costantino D, Kieft JS. A preformed compact ribosome-binding domain in the cricket paralysis-like virus IRES RNAs. RNA 2005; 11: 332-343. DOI: 10.1261/rna.7184705
21. Pfingsten JS, Costantino DA, Kieft JS. Structural basis for ribosome recruitment and manipulation by a viral IRES RNA. Science 2006; 314: 1450-1454. DOI: 10.1126/science.1133281
22. Yamamoto H, Nakashima N, Ikeda Y, et al. Binding mode of the first aminoacyl-tRNA in translation initiation mediated by Plautia stali intestine virus internal ribosome entry site. Journal of Biological Chemistry 2007; 282: 7770-7776. DOI: 10.1074/jbc.M610887200
23. Costantino DA, Pfingsten JS, Rambo RP, et al. tRNA-mRNA mimicry drives translation initiation from a viral IRES. Nature Structural and Molecular Biology 2008; 15: 57-64. DOI: 10.1038/nsmb1351
24. Reynolds JE, Kaminski A, Kettinen HJ, et al. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO Journal 1995; 14: 6010-6020.
25. Wang TH, Rijnbrand RC, Lemon SM. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. Journal of Virology 2000; 74: 11, 347-11, 358.
26. Kieft JS, Zhou K, Jubin R, et al. The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. Journal of Molecular Biology 1999; 292: 513-529.
27. Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 1996; 2: 955-968.
28. Berry KE, Waghray S, Doudna JA. Waghray S, Doudna JA. The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit. RNA 2010; 16: 1559-1569. DOI: 10.1261/rna.2197210
29. Spahn CM, Kieft JS, Grassucci RA, et al. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 2001; 291: 1959-1962.
30. Fraser CS, Doudna JA. Structural and mechanistic insights into hepatitis C viral translation initiation. Nature Reviews Microbiology 2007; 5: 29-38.
31. Terenin IM, Dmitriev SE, Andreev DE, et al. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nature Structural and Molecular Biology 2008; 15: 836-841.
32. Fernández-Miragall O, Martínez-Salas E. Structural organization of a viral IRES depends on the integrity of the GNRA motif. RNA 2003; 9: 1333-1344.
33. Fernández-Miragall O, Martínez-Salas E. In vivo footprint of a picornavirus internal ribosome entry site reveals differences in accessibility to specific RNA structural elements. Journal of General Virology 2007; 88: 3053-3062.
34. Fernández N, Fernández-Miragall O, Ramajo J, et al. Structural basis for the biological relevance of the invariant apical stem in IRES-mediated translation. Nucleic Acids Research 2011; 39: 8572-8585. DOI: 10.1093/nar/gkr560
35. Fernández N, García-Sacristán A, Ramajo J, et al. Structural analysis provides insights into the modular organization of picornavirus IRES. Virology 2011; 409: 251-261. DOI: S0042-6822(10)00649-5
36. López de Quinto S, Martínez-Salas E. Interaction of the eIF4G initiation factor with the aphthovirus IRES is essential for internal translation initiation in vivo. RNA 2000; 6: 1380-1392.
37. López de Quinto S, Lafuente E, Martínez-Salas E. IRES interaction with translation initiation factors: functional characterization of novel RNA contacts with eIF3, eIF4B, and eIF4GII. RNA 2001; 7: 1213-1226.
38. Jang SK, Pestova TV, Hellen CU, et al. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 1990; 44: 292-309.
39. Pilipenko EV, Pestova TV, Kolupaeva VG, et al. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes & Development 2000; 14: 2028-2045.
40. Kolupaeva VG, Lomakin IB, Pestova TV, et al. Eukaryotic initiation factors 4G and 4A mediate conformational changes downstream of the initiation codon of the encephalomyocarditis virus internal ribosomal entry site. Molecular and Cellular Biology 2003; 23: 687-698.
41. Song Y, Tzima E, Ochs K, et al. Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation. RNA 2005; 11: 1809-1824. DOI: 10.1261/rna.7430405
42. Brasey A, Lopez-Lastra M, Ohlmann T, et al. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. Journal of Virology 2003; 77: 3939-3949.
43. Camerini V, Decimo D, Balvay L, et al. A dormant internal ribosome entry site controls translation of feline immunodeficiency virus. Journal of Virology 2008; 82: 3574-3583. DOI: 10.1128/JVI.02038-07
44. Buck CB, Shen X, Egan MA, et al. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. Journal of Virology 2001; 75: 181-191. DOI: 10.1128/JVI.75.1.181-191.2001
45. Abbink TE, Ooms M, Haasnoot PC, et al. The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry 2005; 44: 9058-9066. DOI: 10.1021/bi0502588
46. Abbink TE, Berkhout B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. Journal of Biological Chemistry 2003; 278: 11, 601-11, 611. DOI: 10.1074/jbc.M210291200
47. Edgil D, Harris E. End-to-end communication in the modulation of translation by mammalian RNA viruses. Virus Research 2006; 119: 43-51.
48. Pilipenko EV, Maslova SV, Sinyakov AN, et al. Towards identification of cis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures. Nucleic Acids Research 1992; 20: 1739-1745.
49. Wimmer E, Hellen CU, Cao X. Genetics of poliovirus. Annual Review of Genetics 1993; 27: 353-436. DOI: 10.1146/annurev.ge.27.120193.002033
50. Jacobson SJ, Konings DA, Sarnow P. Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. Journal of Virology 1993; 67: 2961-2971.
51. Wang J, Bakkers JM, Galama JM, et al. Structural requirements of the higher order RNA kissing element in the enteroviral 3'UTR. Nucleic Acids Research 1999; 27: 485-490. DOI: 10.1093/nar/27.2.485
52. Melchers WJ, Bakkers JM, Bruins Slot HJ, et al. Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR. RNA 2000; 6: 976-987.
53. van Ooij MJ, Glaudemans DH, Heus HA, et al. Structural and functional integrity of the coxsackievirus B3 oriR: spacing between coaxial RNA helices. Journal of General Virology 2006; 87: 689-695. DOI: 10.1099/vir.0.81558-0
54. Rodriguez Pulido M, Sobrino F, Borrego B, et al. Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine. Journal of Virology 2009; 83: 3475-3485. DOI: 10.1128/JVI.01836-08
55. Serrano P, Pulido MR, Saiz M, et al. The 3' end of the foot-and-mouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5' end region. Journal of General Virology 2006; 87: 3013-3022.
56. Tanaka T, Kato N, Cho MJ, et al. Structure of the 3' terminus of the hepatitis C virus genome. Journal of Virology 1996; 70: 3307-3312.
57. Blight KJ, Rice CM. Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA. Journal of Virology 1997; 71: 7345-7352.
58. Kolykhalov AA, Feinstone SM, Rice CM. Rice CM. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. Journal of Virology 1996; 70: 3363-3371.
59. Yanagi M, St Claire M, Emerson SU, et al. In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 2291-2295.
60. Kolykhalov AA, Mihalik K, Feinstone SM, et al. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. Journal of Virology 2000; 74: 2046-2051.
61. Friebe P, Bartenschlager R. Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. Journal of Virology 2002; 76: 5326-5338.
62. Yi M, Lemon SM. Structure-function analysis of the 3' stem-loop of hepatitis C virus genomic RNA and its role in viral RNA replication. RNA 2003; 9: 331-345.
63. Yi M, Lemon SM. 3' nontranslated RNA signals required for replication of hepatitis C virus RNA. Journal of Virology 2003; 77: 3557-3568.
64. You S, Rice CM. 3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U). Journal of Virology 2008; 82: 184-195. DOI: JVI.01796-07[pii]10.1128/JVI.01796-07
65. Banerjee R, Dasgupta A. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA. Journal of Virology 2001; 75: 1708-1721.
66. Ito T, Lai MM. Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. Journal of Virology 1997; 71: 8698-8706.
67. Luo G. Cellular proteins bind to the poly(U) tract of the 3' untranslated region of hepatitis C virus RNA genome. Virology 1999; 256: 105-118.
68. Spangberg K, Goobar-Larsson L, Wahren-Herlenius M, et al. The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3' untranslated region. Journal of Human Virology 1999; 2: 296-307.
69. Wood J, Frederickson RM, Fields S, et al. Hepatitis C virus 3'X region interacts with human ribosomal proteins. Journal of Virology 2001; 75: 1348-1358.
70. Chang KS, Luo G. The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA. Virus Research 2006; 115: 1-8.
71. Friebe P, Boudet J, Simorre JP, et al. Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication. Journal of Virology 2005; 79: 380-392.
72. Diviney S, Tuplin A, Struthers M, et al. A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. Journal of Virology 2008; 82: 9008-9022.
73. Brinton MA, Fernandez AV, Dispoto JH. The 3'-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology 1986; 153: 113-121.
74. Davis WG, Blackwell JL, Shi PY, et al. Interaction between the cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. Journal of Virology 2007; 81: 10, 172-10, 187. DOI: 10.1128/JVI.00531-07
75. Sola I, Mateos-Gomez PA, Almazan F, et al. RNA-RNA and RNA-protein interactions in coronavirus replication and transcription. RNA Biology 2011; 8: 237-248. DOI: 10.4161/rna.8.2.14991
76. Hsue B, Masters PS. A bulged stem-loop structure in the 3' untranslated region of the genome of the coronavirus mouse hepatitis virus is essential for replication. Journal of Virology 1997; 71: 7567-7578.
77. Hsue B, Hartshorne T, Masters PS. Masters PS. Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome. Journal of Virology 2000; 74: 6911-6921.
78. Williams GD, Chang RY, Brian DA. A phylogenetically conserved hairpin-type 3' untranslated region pseudoknot functions in coronavirus RNA replication. Journal of Virology 1999; 73: 8349-8355.
79. Goebel SJ, Miller TB, Bennett CJ, et al. A hypervariable region within the 3' cis-acting element of the murine coronavirus genome is nonessential for RNA synthesis but affects pathogenesis. Journal of Virology 2007; 81: 1274-1287. DOI: 10.1128/JVI.00803-06
80. Cuceanu NM, Tuplin A, Simmonds P. Evolutionarily conserved RNA secondary structures in coding and non-coding sequences at the 3' end of the hepatitis G virus/GB-virus C genome. Journal of General Virology 2001; 82: 713-722.
81. Tuplin A, Wood J, Evans DJ, et al. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA 2002; 8: 824-841.
82. Simmonds P, Karakasiliotis I, Bailey D, et al. Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Research 2008; 36: 2530-2546. DOI: 10.1093/nar/gkn096
83. Wang Q, Barr I, Guo F, et al. Evidence of a novel RNA secondary structure in the coding region of HIV-1 pol gene. RNA 2008; 14: 2478-2488. DOI: 10.1261/rna.1252608
84. Victoria M, Colina R, Miagostovich MP, et al. Phylogenetic prediction of cis-acting elements: a CRE-like sequence in Norovirus genome?. BMC Research Notes 2009; 2: 176. DOI: 10.1186/1756-0500-2-176
85. Moss WN, Priore SF, Turner DH. Identification of potential conserved RNA secondary structure throughout influenza A coding regions. RNA 2011; 17: 991-1011. DOI: 10.1261/rna.2619511
86. Liu ZY, Li XF, Jiang T, et al. Novel cis-acting element within the capsid-coding region enhances flavivirus viral-RNA replication by regulating genome cyclization. Journal of Virology 2013; 87: 6804-6818. DOI: 10.1128/JVI.00243-13
87. McKnight KL, Lemon SM. The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA 1998; 4: 1569-1584.
88. Lobert PE, Escriou N, Ruelle J, et al. A coding RNA sequence acts as a replication signal in cardioviruses. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 11, 560-11, 565.
89. Goodfellow I, Chaudhry Y, Richardson A, et al. Identification of a cis-acting replication element within the poliovirus coding region. Journal of Virology 2000; 74: 4590-4600.
90. Paul AV, Rieder E, Kim DW, et al. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. Journal of Virology 2000; 74: 10, 359-10, 370.
91. m of the initiating nucleoside triphosphate for viral RNA replication. Journal of Virology 2008; 82: 9400-9408. DOI: 10.1128/JVI.00427-08
92. You S, Stump DD, Branch AD, et al. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. Journal of Virology 2004; 78: 1352-1366.
93. Lee H, Shin H, Wimmer E, et al. cis-Acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome. Journal of Virology 2004; 78: 10, 865-10, 877.
94. Tuplin A, Struthers M, Simmonds P, et al. A twist in the tail: SHAPE mapping of long-range interactions and structural rearrangements of RNA elements involved in HCV replication. Nucleic Acids Research 2012; 40: 6908-6921. DOI: 10.1093/nar/gks370
95. Palau W, Masante C, Ventura M, et al. Direct evidence for RNA-RNA interactions at the 3' end of the Hepatitis C virus genome using surface plasmon resonance. RNA 2013; 19: 982-991. DOI: 10.1261/rna.037606.112
96. Shetty S, Stefanovic S, Mihailescu MR. Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions? Nucleic Acids Research 2013; 41: 2526-2540. DOI: 10.1093/nar/gks1318
97. Romero-López C, Berzal-Herranz A. A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome. RNA 2009; 15: 1740-1752.
98. Romero-López C, Berzal-Herranz A. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation. Cellular and Molecular Life Sciences 2012; 69: 103-113. DOI: 10.1007/s00018-011-0729-z
99. Romero-López C, Barroso-delJesus A, García-Sacristán A, et al. The folding of the hepatitis C virus internal ribosome entry site depends on the 3'-end of the viral genome. Nucleic Acids Research 2012; 40: 11, 697-11, 713. DOI: 10.1093/nar/gks927
100. McCaffrey AP, Ohashi K, Meuse L, et al. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Molecular Therapy 2002; 5: 676-684.
101. Bradrick SS, Walters RW, Gromeier M. The hepatitis C virus 3'-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase. Nucleic Acids Research 2006; 34: 1293-1303.
102. Song Y, Friebe P, Tzima E, et al. The hepatitis C virus RNA 3'-untranslated region strongly enhances translation directed by the internal ribosome entry site. Journal of Virology 2006; 80: 11, 579-11, 588.
103. Lourenco S, Costa F, Debarges B, et al. Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by cis-acting RNA elements and trans-acting viral factors. FEBS Journal 2008; 275: 4179-4197.
104. Hahn CS, Hahn YS, Rice CM, et al. Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. Journal of Molecular Biology 1987; 198: 33-41. DOI: 10.1016/0022-2836(87)90455-4
105. Alvarez DE, Lodeiro MF, Luduena SJ, et al. Long-range RNA-RNA interactions circularize the dengue virus genome. Journal of Virology 2005; 79: 6631-6643. DOI: 10.1128/JVI.79.11.6631-6643.2005
106. Friebe P, Harris E. Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. Journal of Virology 2010; 84: 6103-6118. DOI: 10.1128/JVI.02042-09
107. Rossi JJ. Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends in Biotechnology 1995; 13: 301-306.
108. Haasnoot J, Berkhout B. Nucleic acids-based therapeutics in the battle against pathogenic viruses. Handbook of Experimental Pharmacology 2009: 243-263. DOI: 10.1007/978-3-540-79086-0_9
109. Crooke ST. Molecular mechanisms of action of antisense drugs. Biochimica et Biophysica Acta 1999; 1489: 31-44.
110. Darfeuille F, Arzumanov A, Gait MJ, et al. 2'-O-methyl-RNA hairpins generate loop-loop complexes and selectively inhibit HIV-1 Tat-mediated transcription. Biochemistry 2002; 41: 12, 186-12, 192. DOI: 10.1021/bi025974d
111. McHutchison JG, Patel K, Pockros P, et al. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. Journal of Hepatology 2006; 44: 88-96.
112. Puerta-Fernández E, Barroso-delJesus A, Romero-López C, et al. Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005; 19: 863-870.
113. Gu S, Ji J, Kim JD, et al. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs. Oligonucleotides 2006; 16: 287-295. DOI: 10.1089/oli.2006.16.287
114. Levine BL, Humeau LM, Boyer J, et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 17, 372-17, 377. DOI: 10.1073/pnas.0608138103
115. Blake SJ, Bokhari FF, McMillan NA. RNA interference for viral infections. Current Drug Targets 2012; 13: 1411-1420. DOI: CDT-EPUB-20120528-25
116. Elmen J, Thonberg H, Ljungberg K, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Research 2005; 33: 439-447. DOI: 10.1093/nar/gki193
117. Boden D, Pusch O, Lee F, et al. Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology 2003; 77: 11, 531-11, 535.
118. Schopman NC, ter Brake O, Berkhout B. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010; 7: 52. DOI: 10.1186/1742-4690-7-52
119. Chandra PK, Kundu AK, Hazari S, et al. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes. Molecular Therapy 2012; 20: 1724-1736. DOI: 10.1038/mt.2012.107
120. Dimitrova M, Affolter C, Meyer F, et al. Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films. Proceedings of the National Academy of Sciences of the United States of America 2008; 105: 16, 320-16, 325. DOI: 10.1073/pnas.0800156105
121. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-822.
122. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-510.
123. Marton S, Reyes-Darias JA, Sánchez-Luque FJ, et al. In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules. Molecules 2010; 15: 4610-4638.
124. Ducongé F, Toulmé JJ. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. RNA 1999; 5: 1605-1614.
125. Darfeuille F, Cazenave C, Gryaznov S, et al. RNA and N3'->P5' kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1. Nucleosides, Nucleotides & Nucleic Acids 2001; 20: 441-449.
126. Darfeuille F, Arzumanov A, Gryaznov S, et al. Loop-loop interaction of HIV-1 TAR RNA with N3'->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 9709-9714.
127. Beaurain F, Di Primo C, Toulmé JJ, et al. Molecular dynamics reveals the stabilizing role of loop closing residues in kissing interactions: comparison between TAR-TAR* and TAR-aptamer. Nucleic Acids Research 2003; 31: 4275-4284.
128. Boucard D, Toulmé JJ, Di Primo C. Bimodal loop-loop interactions increase the affinity of RNA aptamers for HIV-1 RNA structures. Biochemistry 2006; 45: 1518-1524.
129. Lebars I, Richard T, Di Primo C, et al. NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer. Nucleic Acids Research 2007; 35: 6103-6114.
130. Aldaz-Carroll L, Tallet B, Dausse E, et al. Apical loop-internal loop interactions: a new RNA-RNA recognition motif identified through in vitro selection against RNA hairpins of the hepatitis C virus mRNA. Biochemistry 2002; 41: 5883-5893.
131. Kikuchi K, Umehara T, Fukuda K, et al. RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region. Journal of biochemistry (Tokyo) 2003; 133: 263-270.
132. Tallet-López B, Aldaz-Carroll L, Chabas S, et al. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation. Nucleic Acids Research 2003; 31: 734-742.
133. Kikuchi K, Umehara T, Fukuda K, et al. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Nucleic Acids Research 2005; 33: 683-692.
134. Marton S, Romero-López C, Berzal-Herranz A. RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain. Journal of Viral Hepatitis 2013; 20: 103-112. DOI: 10.1111/j.1365-2893.2012.01629.x
135. Romero-López C, Sanchez-Luque FJ, Berzal-Herranz A. Targets and tools: recent advances in the development of anti-HCV nucleic acids. Infectious Disorders Drug Targets 2006; 6: 121-145.
136. James W. Aptamers in the virologists' toolkit. Journal of General Virology 2007; 88: 351-364. DOI: 88/2/351
137. Romero-López C, Barroso-delJesus A, Puerta-Fernáandez E, et al. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method. Biological Chemistry 2005; 386: 183-190.
138. Romero-López C, Díaz-González R, Berzal-Herranz A. Inhibition of hepatitis C virus internal ribosome entry site-mediated translation by an RNA targeting the conserved IIIf domain. Cellular and Molecular Life Sciences 2007; 64: 2994-3006.
139. Zhou J, Li H, Li S, et al. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Molecular Therapy 2008; 16: 1481-1489. DOI: 10.1038/mt.200892
140. Kikuchi K, Umehara T, Nishikawa F, et al. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Biochemical and Biophysical Research Communications 2009; 386: 118-123. DOI: S0006-291X(09)01118-8
141. Romero-López C, Díaz-González R, Barroso-delJesus A, et al. Inhibition of HCV replication and IRES-dependent translation by an RNA molecule. Journal of General Virology 2009; 90: 1659-1669.
142. Romero-López C, Berzal-Herranz B, Gomez J, et al. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication. Antiviral Research 2012; 94: 131-138. DOI: 10.1016/j.antiviral.2012.02.015
143. Wang RE, Wu H, Niu Y, et al. Improving the stability of aptamers by chemical modification. Current Medicinal Chemistry 2011; 18: 4126-4138. DOI: BSP/CMC/E-Pub/2011/ 310
144. Healy JM, Lewis SD, Kurz M, et al. Pharmacokinetics and biodistribution of novel aptamer compositions. Pharmaceutical Research 2004; 21: 2234-2246.
145. Carter AP, Clemons WM, Brodersen DE, et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 2000; 407: 340-348. DOI: 10.1038/35030019.
146. Vicens Q, Westhof E. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure 2001; 9: 647-658. DOI: S0969212601006293
147. Ennifar E, Paillart JC, Marquet R, et al. HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics. Journal of Biological Chemistry 2003; 278: 2723-2730. DOI: 10.1074/jbc.M205726200
148. Ennifar E, Paillart JC, Bodlenner A, et al. Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell. Nucleic Acids Research 2006; 34: 2328-2339. DOI: 10.1093/nar/gkl317
149. Sakuragi J, Ode H, Sakuragi S, et al. A proposal for a new HIV-1 DLS structural model. Nucleic Acids Research 2012; 40: 5012-5022. DOI: 10.1093/nar/gks156
150. Pini A, Falciani C, Bracci L. Branched peptides as therapeutics. Current Protein and Peptide Science 2008; 9: 468-477.
151. Bryson DI, Zhang W, McLendon PM, et al. Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA. ACS Chemical Biology 2012; 7: 210-217. DOI: 10.1021/cb200181v
152. Parsons J, Castaldi MP, Dutta S, et al. Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nature Chemical Biology 2009; 5: 823-825. DOI: 10.1038/nchembio.217
153. Dibrov SM, Ding K, Brunn ND, et al. Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches. Proceedings of the National Academy of Sciences of the United States of America 2012; 109: 5223-5228. DOI: 10.1073/pnas.1118699109